Related Experiment Video

Updated: Jul 7, 2026

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

Endothelaemia--a marker of vascular damage

J Rajec1, J Tisonova, M Kriska

  • 1Department of Pharmacology, Faculty of Medicine, Comenius University, Bratislava, Slovakia. jan.rajec@fmed.uniba.sk

Bratislavske Lekarske Listy
|January 30, 2008
PubMed

Insights

This study found higher circulating endothelial cells (CECs) in patients with advanced cardiovascular disease, indicating vascular injury. These findings support CECs as potential biomarkers for cardiovascular risk assessment.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Biomarker Research

Background:

  • Endothelaemia, a marker of vascular injury, is elevated in high cardiovascular risk patients.
  • Elevated endothelaemia is observed in both cardiovascular and non-cardiovascular conditions.
  • Further research is needed to explore endothelaemia's diagnostic utility in acute coronary syndrome and cardiovascular risk stratification.

Purpose of the Study:

  • To quantify circulating endothelial cells (CECs) in advanced cardiovascular disease patients.
  • To compare CEC levels between cardiovascular patients and a control group.
  • To determine statistically significant differences in CEC levels among patient groups.

Main Methods:

  • Quantitative measurement of endothelaemia using J. Hladovec's method.
  • Isolation of endothelial cells (ECs) with platelets in Bürker's chamber.
  • Removal of platelets via adenosine-diphosphate addition for EC counting.

Main Results:

  • Mean baseline endothelaemia was significantly higher in high cardiovascular risk patients (ACS and PAOD) versus controls.
  • Patients with peripheral artery occlusive disease (PAOD) showed significantly increased endothelaemia post-surgery compared to pre-surgery levels.
  • Statistical significance (p < 0.05) was observed for all key findings.

Conclusions:

  • This pilot study confirms significantly elevated endothelaemia in high cardiovascular risk patients.
  • Findings align with existing data on endothelaemia and vascular injury.
  • Advanced methods like immunomagnetic principles may enhance clinical utility of endothelaemia measurement.
Abstract

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

Related Concept Videos

Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...